Johns Hopkins Surgery Prof: 'I Gave Out Opioids Like Candy'Chris MenahanInformationLiberation Aug. 07, 2017 |
Report: Hamas Says Witkoff Promised to Lift Gaza Blockade in Exchange for Edan Alexander
Ben Shapiro, Mark Levin and Laura Loomer Warn of Foreign Influence... From Qatar
Eloy Adrian Camarillo, 17, Arrested in Shooting Death of Infowars Reporter Jamie White
NYT: Trump Ended War With Houthis After They Shot Down U.S. Drones, Nearly Hit Fighter Jets
Trump Advisor to Washington Post: 'In MAGA, We Are Not Bibi Fans'
![]() ![]() Dr. Marty Makary writes in The Courier Journal: For most of my surgical career, I gave out opioids like candy. My colleagues and I were unaware that about 1 in 16 patients become chronic users, according to new research by doctors at the University of Michigan. Even more alarming, research shows that relapse rates after opioid addiction treatment could be as high as 91 percent. In addition to expanding treatment, it’s time we address the root of the problem — overprescribing.Dr. Makary appeared on Fox News this morning to talk about what a scam this is: No one needs 30 damn tablets of opioids, let alone 90. There's no reason to hand out so many unless the goal is to get people hooked. The Sackler family, who were behind the Oxycontin scam, gave out free samples through their company Purdue Pharma just to get people hooked. ![]() As Jason Smith notes: Purdue even gave out free samples, a curious gesture if you truly believe your product is non-addictive. Using a patient starter coupon, the first dosing was free. By 2001, about 34,000 coupons had been redeemed. By marketing directly to the consumer, Purdue knew that after the first taste — the free taste — many would come back to their doctors demanding another prescription for OxyContin, which is exactly what happened.They've known for decades this drug is insanely addictive yet the Sacklers rode this scam all the way to become one of the top 20 richest families in America according to Forbes. Follow InformationLiberation on Twitter and Facebook. |